SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001564590-19-023504
Filing Date
2019-06-26
Accepted
2019-06-25 18:35:49
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3/A arct-s3a.htm S-3/A 444155
2 EX-4.9 arct-ex49_8.htm EX-4.9 520701
3 EX-5.1 arct-ex51_9.htm EX-5.1 29370
4 EX-23.1 arct-ex231_43.htm EX-23.1 2488
5 EX-23.2 arct-ex232_24.htm EX-23.2 3385
6 GRAPHIC gwhpd3buktkv000001.jpg GRAPHIC 4053
7 GRAPHIC gek2f4y4iwb5000001.jpg GRAPHIC 7028
8 GRAPHIC gwhpd3buktkv000002.jpg GRAPHIC 4053
  Complete submission text file 0001564590-19-023504.txt   1022423
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-232281 | Film No.: 19919614
SIC: 2834 Pharmaceutical Preparations